Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia

被引：59

作者：

Griffith, H. Randall ^{[1
,2
,3
]}

den Hollander, Jan A. ^{[4
]}

Okonkwo, Ozioma C. ^{[3
]}

O'Brien, Timothy ^{[3
]}

Watts, Ray L. ^{[1
,2
]}

Marson, Daniel C. ^{[1
,2
]}

机构：

[1] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA

[2] Univ Alabama Birmingham, Alzheimers Dis Res Ctr, Birmingham, AL 35294 USA

[3] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA

[4] Univ Alabama Birmingham, Dept Med Cardiol, Birmingham, AL 35294 USA

来源：

ALZHEIMERS & DEMENTIA | 2008年 / 4卷 / 06期

关键词：

Parkinson disease; Alzheimer disease; MR spectroscopy; N-acetyl aspartate; Gyrus cinguli;

D O I：

10.1016/j.jalz.2008.04.008

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Background: Few comparative Studies exist of metabolic brain changes among neurodegenerative illnesses. We compared brain metabolic abnormalities in Alzheimer's disease (AD) and in Parkinson's disease with dementia (PDD) as measured by proton magnetic resonance spectroscopy (MRS). Methods: Twelve patients with idiopathic PDD, 22 patients with probable mild AD, and 61 healthy older controls underwent posterior cingulate MRS. Results: Patients with AD exhibited reduced N-acetyl aspartate (NAA)/creatine (Cr) (P <.05) and increased choline (Cho)/Cr (P < 05) and myo-inositol (ml)/Cr (P <.01) compared with controls. Patients with PDD exhibited reduced NAA/Cr (P <.05) and glutamate (Glu)/Cr (P <.01) compared with controls. There was reduced Glu/Cr in PDD compared with AD (P <.01). Conclusions: Patients with AD and patients with PDD exhibited distinct brain metabolic MRS profiles. Findings suggest that comparison of brain MRS profiles across dementias provides useful direction for future Study. (C) 2008 The Alzheimer's Association. All rights reserved.

引用

页码：421 / 427

页数：7

共 50 条

[1] Parkinson's disease and dementia
Padovani, A
Costanizi, C
Gilberti, N
Borroni, B
NEUROLOGICAL SCIENCES, 2006, 27 (Suppl 1) : S40 - S43
[2] Parkinson’s disease and dementia
A. Padovani
C. Costanzi
N. Gilberti
B. Borroni
Neurological Sciences, 2006, 27 : s40 - s43
[3] The effect of donepezil on dementia in Parkinson's disease and Alzheimer's disease.: A pilot study
Rektorová, I
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2004, 67 (05) : 359 - +
[4] Dementia in Parkinson's disease
Caixeta, Leonardo
Vieira, Renata Teles
REVISTA BRASILEIRA DE PSIQUIATRIA, 2008, 30 (04) : 375 - 383
[5] Neuronal Hemoglobin is Reduced in Alzheimer's Disease, Argyrophilic Grain Disease, Parkinson's Disease, and Dementia with Lewy Bodies
Ferrer, Isidro
Gomez, Ana
Carmona, Margarita
Huesa, Gema
Porta, Silvia
Riera-Codina, Miquel
Biagioli, Marta
Gustincich, Stefano
Aso, Ester
JOURNAL OF ALZHEIMERS DISEASE, 2011, 23 (03) : 537 - 550
[6] Brain N-acetylaspartate is reduced in Parkinson disease with dementia
Griffith, Henry Randall
den Hollander, Jan A.
Okonkwo, Ozioma C.
O'Brien, Timothy
Watts, Ray L.
Marson, Daniel C.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2008, 22 (01) : 54 - 60
[7] Prodromes in demyelinating disorders, amyotrophic lateral sclerosis, Parkinson disease, and Alzheimer's dementia
Marrie, R. A.
Maxwell, C. J.
Rotstein, D. L.
Tsai, C. -C.
Tremlett, H.
REVUE NEUROLOGIQUE, 2024, 180 (03) : 125 - 140
[8] Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
Oskar Hansson
Sara Hall
Annika Öhrfelt
Henrik Zetterberg
Kaj Blennow
Lennart Minthon
Katarina Nägga
Elisabet Londos
Shiji Varghese
Nour K Majbour
Abdulmonem Al-Hayani
Omar MA El-Agnaf
Alzheimer's Research & Therapy, 6
[9] DEPRESSION AND DEMENTIA IN PARKINSON'S DISEASE
Akyol, Ali
Ozkul, Ayca
Telli-Turgut, Eylem
Yilmaz, Emine
Akyildiz, Utku
Memis, Sakine
TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2011, 14 (04): : 295 - 299
[10] Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease)
Wlodarek, Dariusz
NUTRIENTS, 2019, 11 (01):

← 1 2 3 4 5 →